Talk:Gonadotropin-releasing hormone agonist
This is the talk page for discussing improvements to the Gonadotropin-releasing hormone agonist article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Gonadotropin-releasing hormone agonist.
|
the most imp section is flare effect and down regulation
it explains the mechanism. we could expand on this section... —Preceding unsigned comment added by 68.61.150.75 (talk) 18:57, 27 December 2009 (UTC)
Control Aging
GnRH treatment represents a potential means of slowing the progress of aging or age-related diseases, the researchers say.
http://news.yahoo.com/brain-region-found-control-aging-191717771.html — Preceding unsigned comment added by 76.176.108.8 (talk) 05:11, 22 January 2014 (UTC)
Proposed deletion of specific drug links from External links section
The specific ones belong on the individual articles (unless any discuss the agents in general) - deleting those 5 would leave just 2. - Rod57 (talk) 16:34, 17 March 2016 (UTC)
External links modified
Hello fellow Wikipedians,
I have just modified 2 external links on Gonadotropin-releasing hormone agonist. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
- Added archive https://web.archive.org/web/20051210124110/http://www.endometriosis.org/gnrh.html to http://www.endometriosis.org/gnrh.html
- Added archive https://web.archive.org/web/20051208062611/http://www.zoladex.com/professional/zoladex/ to http://www.zoladex.com/professional/zoladex/
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}}
(last update: 18 January 2022).
- If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
- If you found an error with any archives or the URLs themselves, you can fix them with this tool.
Cheers.—InternetArchiveBot (Report bug) 16:49, 16 January 2018 (UTC)
Penile atrophy
I heard Dr. William Powers talk about it during his presentations, as well as some anecdotal evidence. But I've been unable to find any other academic sources. Has anyone found any?
Masslan (talk) 18:34, 5 May 2021 (UTC)
Expense
This is bad economics:
GnRH analogues are available as generic medications. Despite this, they continue to be very expensive.
The problem here is that it simply assumes that R&D cost dominates in the case of every medication, and production and distribution are never a primary cost driver.
But quite possibly some drugs are indeed hard to synthesize, or don't have a large usage base to amortize the facilities cost, or are not entirely shelf stable, requiring complex just-in-time manufacture, to pluck a few possibilities out of thin air rather effortlessly.
If there was no cost drop at all between proprietary and generic, then maybe there's some smoke here. — MaxEnt 03:38, 2 November 2021 (UTC)
- Start-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- Start-Class medicine articles
- Mid-importance medicine articles
- Start-Class reproductive medicine articles
- Mid-importance reproductive medicine articles
- Reproductive medicine task force articles
- All WikiProject Medicine articles
- Start-Class women's health articles
- Mid-importance women's health articles
- WikiProject Women's Health articles